YOLFTbeta
SG HealthCare Co., Ltd.

SG HealthCare Co., Ltd.

398120 · KQ · Healthcare / Medical Devices

1,959.00KRW-16.00 (-0.81%)

Price History

Full chart

Market Stats

Previous Close1,975.00
Open1,974.00
Day Range1,890.00 – 1,974.00
52-Week Range1,579.00 – 4,945.00
Volume6.21K
Market Cap26.02B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.17
50-Day Avg1,953.74
200-Day Avg2,889.00

About

SG HealthCare Co., Ltd. provides medical diagnostic equipment. It offers AI, CT, MRI, X-ray, surgical C-arm, ultrasound, dental CBCT, and veterinary solutions for mobile clinics and hospitals. The company is headquartered in Icheon-Si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jung-Soo Kim
  • Employees39
  • Headquarters10 Yangnyeong-ro, Moga-myeon, Icheon-Si, South Korea, 17408, Korea
  • Websitehttps://www.sghealthcare.com

Leadership

  • Mr. Jung-Soo KimChief Executive Officer · b. 1975

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue25.50B27.78B16.10B24.60B
Growth (%)-+8.94%-42.03%+52.76%
Cost of Revenue19.31B20.67B10.95B17.48B
Gross Profit6.19B7.11B5.16B7.12B
Gross Margin24.27%25.60%32.03%28.93%
Operating Expense4.43B4.86B5.83B5.65B
Operating Income1.76B2.25B-673.10M1.47B
Operating Margin6.90%8.09%-4.18%5.96%
EBITDA1.54B3.44B-2.80B2.06B
EBITDA Margin6.03%12.37%-17.40%8.38%
Net Income-450.94M1.77B-3.55B935.60M
Net Income Margin-1.77%6.36%-22.03%3.80%
R&D517.38M557.34M681.85M888.22M
R&D as % of Total Revenue2.03%2.01%4.23%3.61%
Interest Expense1.51B1.02B483.90M385.15M
Interest Expense % of Total Revenue5.92%3.66%3.00%1.57%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets26.00B26.10B32.73B40.51B
Total Liabilities27.61B12.74B10.03B16.15B
Total Equity-1.61B13.29B22.62B23.93B
Cash2.79B1.68B7.53B2.07B
Net Debt6.08B6.88B-6.45B

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.67B606.47M1.11B-4.24B
Capital Expenditure365.87M1.31B4.05B2.65B
Free Cash Flow-2.03B-704.77M-2.94B-6.89B
FCF to OCF121.96%-116.21%-264.28%162.53%

Earnings

Report DateDec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------
EPS Actual-326.59-37.33-34.423.41152.362.43-55.81
Surprise-------
Timing-------

Key Statistics & Ratios

Market Cap26.02B
Enterprise Value26.32B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.00
Price / Book0.96
Revenue (TTM)25.96B
Gross Profit (TTM)8.20B
EBITDA2.41B
Profit Margin4.24%
Operating Margin-17.90%
Return on Equity4.49%
Return on Assets2.88%
Shares Outstanding11.49M
Shares Float8.06M
Beta-0.17
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%